Ohio Innovation Fund — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Clarametyx develops novel immune-enabling therapeutics targeting bacterial biofilms to modify disease progression in patients with chronic respiratory diseases.
BiotechHealthtechMedical DevicesColumbus, US
David Richards(Executive Officer)Peter G. Kleinhenz(Director)Michael Layman(Director)Chuck Bramlage(Director)Larry Edwards(Director)Michael Triplett II(Director)
PartnerFaith Voinovich· led
Co-investorsCincyTechJobsOhio VenturesRev1 Ventures
Trace is a platform for creating and publishing augmented reality experiences across retail, events, training, and real estate.
Deep TechEnterprise SoftwareSaaSColumbus, US
Martin Smith(Director)Melinda Gloriosa(Director)Gregory Tran(Executive Officer)
Co-investorsAllied Venture PartnersPortland Seed FundService Provider Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.